RVRenato Lima Vitorasso

Renato Lima Vitorasso

*This is an algorithmically generated author record based on publicly available information.

Renato Lima Vitorasso has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Economic impact of heart failure in Brazil

    by Nathalia Volpi e Silva, Daniela Vicentini, Renato Lima Vitorasso, Vicky Nogueira-Pileggi, Elizabeth Bilevicius, Vivian Cardoso Batista, Renato Mantelli Picoli

    Heart failure (HF) is highly prevalent worldwide [1] and is the main cause of hospitalisations in developed countries. It is the leading cause of hospitalisations for cardiovascular diseases in Brazil [2], the third leading cause of hospitalisations in general [3], and is associated with increasing healthcare resources utilisation and rising costs [4]. These high […]

  • Open Access

    Unveiling the gap in heart failure: a Brazilian Unified Health System study

    by Nathalia Volpi e Silva, Vicky Nogueira-Pileggi, Renato Lima Vitorasso, Daniela Vicentini, Elizabeth Bilevicius, Vivian Cardoso Batista, Renato Mantelli Picoli

    According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are a leading cause of death worldwide, despite being preventable through behavioural and clinical interventions. They accounted for around 17.9 million deaths in 2019, representing 32% of all global deaths [1]. Heart failure (HF) stands out as a highly prevalent CVD, associated with significant […]

  • Assessment of Lung Ventilators’ Pressure Alarms System in a Controlled Scenario

    by S. G. Mello, A. E. Lino-Alvarado, R. L. Vitorasso, D. A. O. Rosa, M. H. G. Lopes, A. F. G. Ferreira Junior, H. T. Moriya

  • Assessment of Respiratory Mechanics in Mice Using Estimated Input Impedance Without Redundancy

    by V. A. Takeuchi, V. Mori, R. Vitorasso, A. E. Lino-Alvarado, M. A. Oliveira, W. T. Lima, H. T. Moriya

  • Signal processing to remove spurious contributions to the assessment of respiratory mechanics

    by Vitor Mori, Renato L. Vitorasso, Vitor A. Takeuchi, Wothan T. Lima, Maria A. Oliveira, Henrique T. Moriya

    Signal disruptions in small animals during the realization of the Forced Oscillation Technique are a well-known cause of data loss as it leads to non-reliable estimations of the respiratory impedan...


  • Respiratory mechanics during methacholine bolus and continuous infusion protocols in asthma model

    by Renato Lima Vitorasso, Maria Aparecida Oliveira, Wothan Tavares-De-Lima, Henrique Takachi Moriya


  • Drug class effects on respiratory mechanics in animal models: access and applications

    by Maria A Oliveira, Alembert E Lino-Alvarado, Henrique T Moriya, Renato L Vitorasso

    Assessment of respiratory mechanics extends from basic research and animal modeling to clinical applications in humans. However, to employ the applications in human models, it is desirable and sometimes mandatory to study non-human animals first. To acquire further precise and controlled signals and parameters, the animals studied must be further distant from their spontaneous ventilation. The majority of respiratory mechanics studies use positive pressure ventilation to model the respiratory system. In this scenario, a few drug categories become relevant: anesthetics, muscle blockers, bronchoconstrictors, and bronchodilators. Hence, the main objective of this study is to briefly review and discuss each drug category, and the impact of a drug on the assessment of respiratory mechanics. Before and during the positive pressure ventilation, the experimental animal must be appropriately sedated and anesthetized. The sedation will lower the pain and distress of the studied animal and the plane of anesthesia will prevent the pain. With those drugs, a more controlled procedure is carried out; further, because many anesthetics depress the respiratory system activity, a minimum interference of the animal’s respiration efforts are achieved. The latter phenomenon is related to muscle blockers, which aim to minimize respiratory artifacts that may interfere with forced oscillation techniques. Generally, the respiratory mechanics are studied under appropriate anesthesia and muscle blockage. The application of bronchoconstrictors is prevalent in respiratory mechanics studies. To verify the differences among studied groups, it is often necessary to challenge the respiratory system, for example, by pharmacologically inducing bronchoconstriction. However, the selected bronchoconstrictor, doses, and administration can affect the evaluation of respiratory mechanics. Although not prevalent, studies have applied bronchodilators to return (airway resistance) to the basal state after bronchoconstriction. The drug categories can influence the mathematical modeling of the respiratory system, systemic conditions, and respiratory mechanics outcomes.


  • Respiratory mechanics evaluation of mice submitted to intravenous methacholine: Bolus vs. continuous infusion

    by Renato de L Vitorasso, Maria A de Oliveira, Wothan Tavares-De-Lima, Henrique T Moriya

    The application of a bronchoconstrictor, usually Methacholine (MCh), in respiratory mechanics studies is usually accompanied by the assessment of respiratory mechanics in a dose–response curve. The MCh used in the dose–response curve can be inhaled (i.h.) and intravenous (i.v.) and there are studies comparing i.v. bolus and i.h. MCh in both mice and rats. However, MCh i.v. can be injected at short time interval (bolus) or in continuous infusion. This comparison is relevant since the way MCh is applied influences the mathematical model. We chose an aging process scenario to compare both protocols. This study aims to compare respiratory mechanics of 3-, 6-, and 10-month SAMR1 mice and how both administration methods (continuous infusion and bolus) impact respiratory mechanics evaluation. Both protocols were capable of assessing the difference among ages and doses in: peak or plateau; and area under the curve analysis. The respiratory mechanics parameters were Rn, G, and H (two-way analysis of variance: groups and doses with a P < 0.05 for all). Also, the infusion protocol presented a higher sensitivity to dose increment. In conclusion, both protocols were able to discriminate intragroup and intergroup differences. In the bolus protocol, the highest value of each curve dose may not correspond to the highest real value, and the loss of this point may be a problematic factor in the sample size. These factors are not present in the infusion protocol. Additionally, at this lineage and age screening, the infusion protocol appeared to be more sensitive to differences among ages when compared to the bolus protocol. Impact statement: Respiratory mechanics studies are associated with fundamental research and translational studies; the present work thus investigates this particular matter. Our current research describes differences and similarities between two different ways of administrating a very prevalent bronchoconstrictor (methacholine) in an aging process scenario. The core issue of our work is related with troubles we find with the bolus protocol and the application of the mathematical model used to assess the respiratory mechanics. Our findings reveal the continuous infusion as an alternative to these problems and we hope to provide the proper foundations to a more reliable assessment in the respiratory field.


  • Methacholine dose response curve and acceptability criteria of respiratory mechanics modeling

    by Renato de L. Vitorasso, Vitor Mori, Maria A. Oliveira, Andre S. Suaiden, Wothan Tavares-De-Lima, Henrique T. Moriya

    Aim: This study aimed to analyze the Constant Phase Model (CPM) Coefficient of Determination (COD) and an index of harmonic distortion ( kd) behavior in intravenous methacholine dose response curve. We studied the COD and kd behavior of Control and Lung Inflammation (OVA) groups of mice and we proposed an alternative for moments when the CPM should not be applied. Methods: 9-week female BALB/c mice were studied, 8 of the control group (23.11 ± 1.27 g) and 11 of the lung inflammation group (OVA) (21.45 ± 2.16 g). The COD values were obtained during the respiratory mechanics assessment via Forced Oscillation Technique (FOT) and the kd was estimated a posteriori. Both control and OVA groups were submitted to 4 doses of Methacholine (MCh) protocol. Results: A strong correlation between COD and kd was present at the last two doses (0.3 mg/kg: r = −0.75, p = 0.0013 and 1 mg/kg: r = −0.91; p < 0.0001) in the OVA group. Differences were found in doses of 0.3 mg/kg between control and OVA for the maximum values of Rn (Newtonian Resistance) and G (tissue viscous); and between groups at PBS and doses of 0.03, 0.1 and 0.3 mg/kg for H (Elastance). A similar behavior was observed for the analysis of Area Under the Curve with the exclusion of the 3 first measurements of each dose. However, in this scenario, the comparison with the maximum value presented a higher discriminatory capacity of the parameters associated with the parenchyma. Conclusions: During severe bronchoconstriction there is a strong negative correlation between model goodness of fit and nonlinearities levels, reinforcing that COD is a robust acceptance criterion, whether still simple and easily obtained from the ventilator. We also pointed out the area under the CPM parameters dose response curve is a useful and can be used as a complementary analysis to peak comparison following bolus injections of methacholine.


  • Open Access

    An overview of machine learning in health related areas: pitfalls and opportunities

    by Renato de Lima Vitorasso, Carolina de Souza Ribeiro Vitorasso

    An overview of machine learning in health related areas: pitfalls and opportunities / Uma visão geral do aprendizado de máquina em áreas relacionadas à saúde: armadilhas e oportunidades